Trial Profile

A Phase I/II Study to Determine Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19 in UK Healthy Adult Volunteers

Status: Active, no longer recruiting

Phase of Trial: Phase I/II

Latest Information Update: 28 Apr 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AZD 1222 (Primary) ; Meningococcal vaccine groups A C Y W-135 conjugate; Paracetamol
Indications COVID 2019 infections
Focus Adverse reactions; Therapeutic Use
Acronyms COV001

Most Recent Events

31 Jul 2023 Planned End Date changed from 31 Mar 2023 to 31 Mar 2024.
31 Jul 2023 Planned primary completion date changed from 31 Mar 2023 to 31 Mar 2024.
20 Jan 2022 Planned End Date changed from 31 Mar 2022 to 31 Mar 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com